4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-21-015020
Options or other derivatives
- CTO acquired 0 shares (grant or award)
- CTO acquired 0 shares (option exercise)
- CTO acquired 1,393,276 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| WACHTER ERIC PHD CTO | 2021-06-17 | Grant or award · 8% Secured Convertible Promissory Notes due 2021 | +0 | D: show line 1 in the form | ||||||
| WACHTER ERIC PHD CTO | 2021-06-20 | Option exercise · 8% Secured Convertible Promissory Notes due 2021 | −0 | 0 | D: show line 2 in the form | |||||
| WACHTER ERIC PHD CTO | 2021-06-20 | Option exercise · Series D-1 Convertible Preferred Stock | +1,393,276 | 1,393,276 | D: show line 3 in the form |
Loading xslF345X03/ownership.xml…